Atsushi Yoshimori Selected Research

Atsushi Yoshimori Research Topics

Disease

16	Neoplasms (Cancer) 04/2022 - 07/2005
4	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2021 - 05/2004
3	Inflammation (Inflammations) 03/2021 - 06/2007
3	Hypoxia (Hypoxemia) 01/2021 - 01/2018
2	Leukemia 01/2022 - 01/2016
2	Sepsis (Septicemia) 10/2021 - 01/2019
2	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 05/2004
2	Lung Neoplasms (Lung Cancer) 01/2017 - 01/2016
2	Breast Neoplasms (Breast Cancer) 08/2010 - 01/2008
2	Virus Diseases (Viral Diseases) 06/2007 - 05/2004
1	Carcinogenesis 03/2021
1	Colonic Neoplasms (Colon Cancer) 01/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Vascular Diseases (Vascular Disease) 06/2020
1	Infections 01/2019
1	Carcinoma (Carcinomatosis) 01/2018
1	Neuralgia (Stump Neuralgia) 10/2017
1	Pain (Aches) 10/2017
1	Genomic Instability 01/2016
1	Ovarian Neoplasms (Ovarian Cancer) 07/2004
1	Hepatitis 05/2004
1	Acquired Immunodeficiency Syndrome (AIDS) 05/2004
1	Huntington Disease (Huntington's Disease) 05/2004

Drug/Important Bio-Agent (IBA)

7	EnzymesIBA 12/2019 - 06/2007
6	Pharmaceutical PreparationsIBA 01/2022 - 07/2005
5	Peptides (Polypeptides)IBA 08/2021 - 07/2004
5	Lactoylglutathione LyaseIBA 01/2021 - 07/2011
4	Proteins (Proteins, Gene)FDA Link 04/2022 - 07/2005
4	3- (1,3- benzothiazol- 2- yl)- 4- (4- methoxyphenyl)but- 3- enoic acidIBA 01/2021 - 07/2011
4	Pyruvaldehyde (Methylglyoxal)IBA 12/2019 - 07/2011
3	PapaverineIBA 03/2021 - 01/2019
3	CaspasesIBA 05/2008 - 05/2004
2	Receptor for Advanced Glycation End ProductsIBA 12/2020 - 01/2019
2	3,3',4,5'-tetrahydroxystilbeneIBA 12/2019 - 01/2017
1	Transcription Factors (Transcription Factor)IBA 04/2022
1	Messenger RNA (mRNA)IBA 04/2022
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2022
1	TrimebutineIBA 10/2021
1	Antiviral Agents (Antivirals)IBA 08/2021
1	Elongation Factor 2 KinaseIBA 05/2021
1	Phosphotransferases (Kinase)IBA 03/2021
1	Interleukin-6 (Interleukin 6)IBA 03/2021
1	Alkenes (Olefins)IBA 01/2021
1	Amyloid (Amyloid Fibrils)IBA 01/2021
1	CollagenIBA 01/2021
1	CurcuminIBA 01/2021
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2021
1	Nicotinamide PhosphoribosyltransferaseIBA 08/2020
1	StilbenesIBA 12/2019
1	HMGB1 Protein (HMG1)IBA 01/2019
1	Morphine (MS Contin)FDA LinkGeneric 10/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2016
1	Poly Adenosine Diphosphate RiboseIBA 01/2016
1	NAD (NADH)IBA 01/2016
1	Adenosine Diphosphate (ADP)IBA 01/2016
1	Paclitaxel (Taxol)FDA LinkGeneric 08/2010
1	pertuzumabIBA 08/2010
1	Cisplatin (Platino)FDA LinkGeneric 07/2005
1	Etoposide (VP 16)FDA LinkGeneric 07/2005
1	NK 109IBA 07/2005
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 07/2005
1	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2005
1	Fas Ligand Protein (Fas Ligand)IBA 07/2004
1	PolylysineIBA 07/2004

Therapy/Procedure

1	Stents 06/2020
1	Punctures 01/2019
1	Ligation 01/2019
1	Analgesia 10/2017
1	Drug Therapy (Chemotherapy) 01/2016